Clinical Trial Update: Targeting GABA-A for the Treatment of Social Disability in Young Adults With Autism Spectrum Disorders: A Phase II Proof of Mechanism Trial [Phase 2]

View source ↗

Summary

A Phase II proof-of-mechanism trial evaluating a GABA-A targeted approach for improving social disability in young adults with autism spectrum disorder has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• GABA-A receptor modulator (investigational)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Autism Spectrum Disorder | Phase 2 | Status: COMPLETED